SWEDISH ORPHAN/S (SWTUY) News Today $24.38 -0.29 (-1.18%) As of 04/9/2019 Add Compare Share Share Headlines Stock AnalysisBuy This Stock SWTUY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Swedish Drugmaker Sobi Doesn’t See Pharma Tariffs as ‘Imminent’July 16, 2025 | bloomberg.comSwedish Orphan Biovitrum AB: Sobi and Apellis: Aspaveli/Empaveli Demonstrates Sustained One-Year Efficacy in Phase 3 Study for Rare Kidney DiseasesJune 6, 2025 | finanznachrichten.deSwedish Orphan Biovitrum AB: Sobi to share new clinical data and research at EULAR 2025May 28, 2025 | finanznachrichten.deBerenberg cuts SOBI stock target to SEK360, maintains buyApril 18, 2025 | uk.investing.comRBC Capital Remains a Buy on Swedish Orphan Biovitrum AB (0MTD)January 14, 2025 | markets.businessinsider.comSobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune ThrombocytopeniaDecember 12, 2024 | markets.businessinsider.comSobi North America Says SNDA Accepted For Avatrombopag In Paediatric Immune ThrombocytopeniaDecember 12, 2024 | markets.businessinsider.comSobi to present new data across its immunology portfolio at the ACR Convergence 2024November 7, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB: Sobi Q3 2024 report: Strong growth and significant pipeline momentumOctober 24, 2024 | finanznachrichten.deSobi Q3 2024 report: Strong growth and significant pipeline momentumOctober 24, 2024 | finance.yahoo.comMerck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In InfantsOctober 18, 2024 | benzinga.comMerck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)October 18, 2024 | msn.comHigh Growth Tech Stocks In Sweden With Promising PotentialOctober 17, 2024 | finance.yahoo.comMerck's RSV antibody for infants shows over 60% efficacy in mid-late-stage studyOctober 17, 2024 | reuters.comExploring Sweden's High Growth Tech GiantsOctober 2, 2024 | uk.finance.yahoo.comNew Swedish law enables government funding for babysitting grandparentsSeptember 27, 2024 | yahoo.comLanguage in sexual offense judgments in Swedish courts makes victims responsibleSeptember 19, 2024 | msn.comThe Best Shows on Max Right Now (September 2024)September 15, 2024 | msn.comHigh Growth Tech Stocks In Sweden To Watch This September 2024September 13, 2024 | finance.yahoo.comHigh Growth Swedish Tech Stocks To Watch In September 2024September 11, 2024 | finance.yahoo.comSwedish Orphan Biovitrum AB: Sobi has completed issues of class C sharesAugust 29, 2024 | finanznachrichten.deAstraZeneca Is a Cancer Leader. Obesity Could Be a Bonus.August 20, 2024 | msn.comHigh Growth Tech Stocks In Sweden To Watch This August 2024August 20, 2024 | uk.finance.yahoo.comSwedish Orphan Biovitrum AB (publ) (0MTD.L)August 17, 2024 | nz.finance.yahoo.comSweden's $2M Submarine Hunt: A Tale of Missteps and MisidentificationsAugust 14, 2024 | msn.comApellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney DiseasesAugust 8, 2024 | msn.comApellis, Sobi Shares Rise on Positive Results for Kidney Disease TreatmentAugust 8, 2024 | marketwatch.comSwedish Orphan Biovitrum AB: Sobi and Apellis announce positive topline results from phase 3 VALIANT study of pegcetacoplan in C3G and primary IC-MPGNAugust 8, 2024 | finanznachrichten.deNasal Sprays Reduce Sick Days From Respiratory Illnesses in High-Risk PatientsJuly 19, 2024 | msn.comBerGenBio ASA: BerGenBio Announces NCI Clinical Collaboration with UT Health San Antonio and Sobi®May 28, 2024 | finanznachrichten.deUkraine-Russia news – live: Putin’s troops ‘massing on Ukrainian border’ as they ‘prepare for fresh offensive’May 27, 2024 | news.yahoo.comSobi, Inc.: Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation SyndromeMay 25, 2024 | finanznachrichten.deSobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation SyndromeMay 24, 2024 | finance.yahoo.comGermany's foreign minister visits Kyiv as Ukraine battles to hold off a Russian offensiveMay 21, 2024 | msn.comSwedish Orphan Biovitrum AB SOBIMay 14, 2024 | morningstar.comMSwedish Orphan Biovitrum AB: Aspaveli® (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNHMay 8, 2024 | finanznachrichten.deDenmark's new monarchs visit Sweden on first official trip abroadMay 6, 2024 | foxnews.comDeciphera to sell for $2.4B, adding to upswing in biopharma M&AApril 29, 2024 | finance.yahoo.comMore premature babies born following Swedish parental leave policyApril 8, 2024 | msn.comSwedish Scientists Confirm: Knitting Is Your Brain's Best FriendApril 3, 2024 | msn.comBulgarian cruise ship crashes into wall on Danube in Austria, injuring 11March 30, 2024 | msn.comCrown Princess Victoria of Sweden, Swedish Minister Johan Forssell to visit Bangladesh March 18-21March 17, 2024 | msn.comSweden set to become NATO's 32nd member as PM visits WashingtonMarch 7, 2024 | msn.comDeath and grief in Swedish children's booksFebruary 21, 2024 | msn.comUPDATE 2-Sweden's Vattenfall to move ahead with nuclear plansFebruary 19, 2024 | msn.comOrexo and Sobi agree to advance feasibility study with AmorphOXFebruary 12, 2024 | finanznachrichten.deRevolutionizing Historical Research: Swedish Lion AI UnveiledFebruary 10, 2024 | msn.comHere's what Wall Street expects from Swedish Orphan Biovitrum AB's earnings reportFebruary 8, 2024 | markets.businessinsider.comClues from the ice age can help restore Swedish streamsFebruary 6, 2024 | msn.comA Day Trip To Uppsala, Sweden’s City Of HistoryJanuary 19, 2024 | forbes.com Get SWEDISH ORPHAN/S News Delivered to You Automatically Sign up to receive the latest news and ratings for SWTUY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SWTUY Media Mentions By Week SWTUY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SWTUY News Sentiment▼0.000.70▲Average Medical News Sentiment SWTUY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SWTUY Articles This Week▼00▲SWTUY Articles Average Week Get the Latest News and Ratings for SWTUY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for SWEDISH ORPHAN/S and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Epiroc AB (publ) News Today OMV Aktiengesellschaft News Today Nitori News Today DS Smith News Today FIH Mobile News Today Spirax-Sarco Engineering News Today Aurora Cannabis News Today Croda International News Today Suntec Real Estate Investment Trust News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SWTUY) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SWEDISH ORPHAN/S Please log in to your account or sign up in order to add this asset to your watchlist. Share SWEDISH ORPHAN/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SWTUY Stock Alerts